Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Jun. 25];2:S117. Available from: https://skin.dermsquared.com/skin/article/view/499